MX390453B - Administracion nasal. - Google Patents

Administracion nasal.

Info

Publication number
MX390453B
MX390453B MX2016017038A MX2016017038A MX390453B MX 390453 B MX390453 B MX 390453B MX 2016017038 A MX2016017038 A MX 2016017038A MX 2016017038 A MX2016017038 A MX 2016017038A MX 390453 B MX390453 B MX 390453B
Authority
MX
Mexico
Prior art keywords
subject
nasal administration
nosepiece
delivering
substance
Prior art date
Application number
MX2016017038A
Other languages
English (en)
Spanish (es)
Other versions
MX2016017038A (es
Inventor
John Messina
Per Gisle Djupesland
Ramy A Mahmoud
Original Assignee
Optinose Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/315,132 external-priority patent/US11554229B2/en
Application filed by Optinose Inc filed Critical Optinose Inc
Publication of MX2016017038A publication Critical patent/MX2016017038A/es
Publication of MX390453B publication Critical patent/MX390453B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0098—Activated by exhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2016017038A 2014-06-25 2015-06-25 Administracion nasal. MX390453B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/315,132 US11554229B2 (en) 2013-03-26 2014-06-25 Nasal administration
PCT/EP2015/064463 WO2015197798A1 (en) 2014-06-25 2015-06-25 Nasal administration

Publications (2)

Publication Number Publication Date
MX2016017038A MX2016017038A (es) 2017-05-01
MX390453B true MX390453B (es) 2025-03-19

Family

ID=53489954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016017038A MX390453B (es) 2014-06-25 2015-06-25 Administracion nasal.

Country Status (14)

Country Link
EP (2) EP3160556A1 (https=)
JP (2) JP6785227B2 (https=)
KR (1) KR102458964B1 (https=)
CN (1) CN106470724A (https=)
AU (3) AU2015279154A1 (https=)
BR (1) BR112016029926A2 (https=)
CA (1) CA2953207A1 (https=)
ES (1) ES3034743T3 (https=)
IL (1) IL249585B (https=)
MX (1) MX390453B (https=)
RU (1) RU2016152090A (https=)
SG (1) SG11201610685XA (https=)
WO (1) WO2015197798A1 (https=)
ZA (1) ZA201608785B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201713899D0 (en) * 2017-08-30 2017-10-11 Indosys Ltd Multi-dose medicament delivery device
US11744967B2 (en) * 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN108421138A (zh) * 2017-12-25 2018-08-21 宫本海 一种鼻腔雾化吸药器
WO2019222463A1 (en) * 2018-05-16 2019-11-21 Massachusetts Institute Of Technology Methods and apparatus for passive, proportional, valveless gas sampling and delivery
EP4051107A4 (en) 2019-10-28 2023-11-01 The Research Foundation for The State University of New York DEVICES, SYSTEMS AND METHODS FOR MONITORING ARTERIAL CARBON DIOXIDE

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB0121568D0 (en) * 2001-09-06 2001-10-24 Optinose As Nasal delivery device
CN1736502A (zh) 1999-03-03 2006-02-22 奥普蒂诺斯公司 鼻传送装置
JP4932109B2 (ja) * 1999-07-12 2012-05-16 キャプニア インコーポレイテッド 頭痛、鼻炎及び他のありふれた病気を治す方法及び装置
US20070039615A1 (en) * 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
EP1259282A4 (en) 2000-02-28 2007-05-23 Capnia Inc METHOD AND DEVICE FOR THE TRANSCUTANEOUS INFUSION OF CARBON DIOXIDE FOR LOCAL PAIN TREATMENT AND THE TREATMENT OF OTHERS
ZA200306564B (en) * 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB2403154B (en) * 2002-04-04 2007-01-24 Optinose As Nasal devices
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB0320171D0 (en) * 2003-08-28 2003-10-01 Optinose As Delivery devices
EP1658105B1 (en) * 2003-08-29 2018-03-14 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
MX2007001561A (es) * 2004-08-04 2007-04-16 Schering Corp Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
GB0503738D0 (en) * 2005-02-23 2005-03-30 Optinose As Powder delivery devices
GB0602980D0 (en) * 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB2440316A (en) * 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
US8337817B2 (en) * 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
GB2448193A (en) * 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) * 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
WO2009095684A1 (en) * 2008-02-01 2009-08-06 Vectura Limited Pulmonary formulations of triptans
US20100196483A1 (en) * 2009-02-04 2010-08-05 Activaero Gmbh Research & Development Method for treatmentof severe and uncontrollable asthma
DE102011103347B4 (de) * 2011-05-27 2014-10-30 Meda Pharma Gmbh & Co. Kg Nasale pharmazeutische Formulierung
MX2014009898A (es) * 2012-02-16 2015-07-06 Capnia Inc Dispensador de gas con boquilla de difusion.
ES2920802T3 (es) * 2013-03-26 2022-08-09 Optinose As Administración nasal

Also Published As

Publication number Publication date
CN106470724A (zh) 2017-03-01
BR112016029926A2 (pt) 2017-08-22
JP6785227B2 (ja) 2020-11-18
RU2016152090A (ru) 2018-07-27
MX2016017038A (es) 2017-05-01
ES3034743T3 (en) 2025-08-22
ZA201608785B (en) 2019-10-30
WO2015197798A1 (en) 2015-12-30
EP4233950C0 (en) 2025-06-25
RU2016152090A3 (https=) 2019-02-15
EP3160556A1 (en) 2017-05-03
IL249585B (en) 2021-04-29
EP4233950A1 (en) 2023-08-30
SG11201610685XA (en) 2017-01-27
JP7090124B2 (ja) 2022-06-23
KR20170035919A (ko) 2017-03-31
KR102458964B1 (ko) 2022-10-25
EP4233950B1 (en) 2025-06-25
AU2015279154A1 (en) 2017-01-12
JP2017520364A (ja) 2017-07-27
AU2021215246A1 (en) 2021-09-09
IL249585A0 (en) 2017-02-28
CA2953207A1 (en) 2015-12-30
JP2020179191A (ja) 2020-11-05
AU2020202029A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
MX2015013774A (es) Administracion nasal.
GEP20247634B (en) Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
PT3613432T (pt) Métodos para tratar a polipose nasal através da administração de um antagonista de il-4r
SA518392270B1 (ar) إنتاج ملاط ثلجي طبي وأنظمة توصيل وطرق
EP3091229A4 (en) Method of driving constant volume pump, device for driving constant volume pump, vaporizer and anesthesia device
EP3556858A3 (en) Crispr/cas-related methods and compositions for treating cystic fibrosis
MX2016009476A (es) Aparatos para tratamiento de heridas.
EA201791223A1 (ru) Процесс для управления уровнем содержания гликанов гликопротеина
EP3113821A4 (fr) Masque facial pour inhalation, adapte a l'administration d'un gaz ou d'une molécule thérapeutique dans le cadre d'un traitement par inhalation, en particulier chez les enfants
MX2015010191A (es) Metodos para tratar infecciones microbianas, incluyendo mastitis.
MX383277B (es) Plasmido que codifica a un agonista coestimulador.
BR112017018620A2 (pt) método de administração de tradipitanto, e, tradipitanto.
MX390453B (es) Administracion nasal.
EP3223901A4 (en) Substance delivery arrangement for gas therapy device
WO2018217710A8 (en) Micro-nanobubble solutions for tissue preservation and generation thereof
EA202091873A2 (ru) Способы лечения гипотонии
MX2017004521A (es) Aparato y metodos para producir y suministrar un medicamento en vapor.
GB2553439A (en) Methods for scoring chromosomal instabilities
PH12017500602A1 (en) Methods for treating ocular conditions
MX2018004361A (es) Nuevos compuestos para el tratamiento de la fibrosis quistica.
MX2017007245A (es) Metodos de tratamiento de la fibrosis.
MX2018004020A (es) Dispositivo y método para la dispersión de no de concentración alta con gas de terapia de inhalación.
GEAP201814463A (en) Pharmaceutical composition for use in increasing the trophism of nasal mucosa
MX2016002485A (es) Composiciones y metodos para el tratamiento de condiciones nasales.
MX2016013979A (es) Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina.